Zaragoza San Sebastian€¦ · MIS Sequence of treatment in crc with synchronous metastases MIS...
Transcript of Zaragoza San Sebastian€¦ · MIS Sequence of treatment in crc with synchronous metastases MIS...
esmocongress.org
Organiser
PROGRAMMEOVERVIEW
ESMO 2014
26-30 SEPTEMBER 2014MadridSpain
Mon
day,
29 S
eptem
ber
Mad
ridBa
rcelo
naSe
villa
Gran
ada
Cord
oba
Pam
plon
aVa
lenc
iaAl
ican
teBi
lbao
Sala
man
caSa
n Seb
astia
nZa
rago
za
08:0
0
08:3
0
09:0
0
09:3
0
10:0
0
10:3
0
11.0
0
11:3
0
12:0
0
12:3
0
13:0
0
13:3
0
14:0
0
14:3
0
15:0
0
15:3
0
16:0
0
16:3
0
17:0
0
17:3
0
18:0
0
18:3
0
19:0
0
19:3
0
20:0
0
CON
TRO
VER
SY
SESS
ION
3
CON
TRO
VER
SY
SESS
ION
4
CON
TRO
VER
SY
SESS
ION
5
CON
TRO
VER
SY
SESS
ION
6
CON
TRO
VER
SY
SESS
ION
7
PATI
ENT
CASE
S
Trea
tmen
t of C
RPC
in
spec
ial s
ituat
ions
PATI
ENT
CASE
S
Chal
leng
es in
man
agin
g br
east
canc
er in
youn
g pa
tient
s
PATI
ENT
CASE
S
Dem
onst
ratin
g the
em
erge
nce o
f res
ista
nce
PATI
ENT
CASE
S
Prim
ary s
urge
ry o
r ne
oadj
. che
mo
ovar
ian/
pt se
lect
ion
CYE
Adju
vant
trea
tmen
t of
brea
st ca
ncer
CYE
SCLC
: Cur
rent
ap
proa
ches
and R
T in
exte
nsiv
e dis
ease
CYE
Thro
mbo
embo
lic
diso
rder
s in o
ncol
ogy
CYE
Curre
nt d
iagn
osis
and
treat
men
t of C
UP
YO B
REA
KFAS
T
Doct
or/p
t rel
atio
nshi
p
YO F
OR
UM
Tips
and t
ricks
for
canc
er re
sear
cher
s in
train
ing
YO S
PECI
AL S
ESSI
ON
Fello
wshi
ps in
Eu
rope
: Edu
catio
nal
oppo
rtuni
ties f
or yo
ung
onco
logi
sts
SPEC
IAL
SESS
ION
How
clin
ical
tria
ls co
uld
have
bee
n don
e, an
d we
re n
ot, i
n rar
e can
cers
SPEC
IAL
SYM
POSI
UM
Activ
atin
g im
mun
e re
spon
se to
canc
er
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
PRO
FFER
ED P
APER
JOIN
T SY
MPO
SIU
M
ESM
O-E
STR
O-E
SSO
Inte
grat
ion o
f loca
l ther
apy
with
syst
emic
treat
men
t in
olig
omet
asta
tic br
east
ca
ncer
JOIN
T SY
MPO
SIU
M
ESM
O-S
EOM
Inve
stig
atio
n driv
en
prec
ision
onco
logy
JOIN
T SY
MPO
SIU
M
ESM
O-E
ANM
Impa
ct o
f mol
ecul
ar
imag
ing o
n man
agem
ent
of ly
mph
oma
SPEC
IAL
SYM
POSI
UM
The e
volv
ing r
ole o
f sy
stem
ic tr
eatm
ent i
n ad
vanc
ed N
SCLC
SPEC
IAL
SYM
POSI
UM
Beyo
nd tu
mou
r he
tero
gene
ity: N
ew
path
ways
in ki
dney
ca
ncer
SPEC
IAL
SYM
POSI
UM
Canc
er im
mun
othe
rapy
in
bre
ast c
ance
r: Dr
eam
or
real
ity?
JOIN
T SY
MPO
SIU
MES
MO
-ASC
O
The e
volu
tion o
f the
cl
inic
al tr
ials
land
scap
e
SPEC
IAL
SYM
POSI
UM
The i
mpa
ct o
n he
alth
serv
ices
from
pe
rson
alis
ed ta
rget
ed
ther
apie
s
SPEC
IAL
SYM
POSI
UM
Diag
nost
ic an
d th
erap
eutic
chal
leng
es
in th
orac
ic m
alig
nanc
ies
SPEC
IAL
SYM
POSI
UM
Towa
rds p
erso
nalis
ed
med
icin
e in g
astri
c,
panc
reat
ic an
d liv
er
canc
er: F
rom
“om
ics”
re
sear
ch to
trea
tmen
t
SPEC
IAL
SYM
POSI
UM
Cont
rove
rsie
s in t
he
neo-
adju
vant
trea
tmen
t of
loca
lised
soft
tissu
e sa
rcom
as (S
TS)
SPEC
IAL
SESS
ION
Prec
isio
n med
icin
e :
Pana
cea o
r fal
se d
awn?
EDU
CATI
ON
AL S
ESSI
ON
Upda
te o
n all
neur
oend
ocrin
e tum
ours
EDU
CATI
ON
AL S
ESSI
ON
Optim
isin
g the
trea
tmen
t of
colo
rect
al ca
ncer
EDU
CATI
ON
AL S
ESSI
ON
Maj
or ly
mph
oma
subt
ypes
in th
e eld
erly
EDU
CATI
ON
AL S
ESSI
ON
Canc
er in
youn
g adu
lts
(18-
35)
MIS
Loca
lly ad
vanc
ed
panc
reat
ic ca
ncer
PATI
ENT
CASE
S
Imag
ing d
ecis
ions
in
hae
mat
olog
ical
m
alig
nanc
ies
PATI
ENT
CASE
S
Imm
unot
hera
py in
cl
inic
al p
ract
ice
MIS
Sequ
ence
of t
reat
men
t in
crc w
ith sy
nchr
onou
s m
etas
tase
s
MIS
Mul
tidis
cipl
inar
y m
gmt o
f per
itone
al
carc
inom
atos
is
PATI
ENT
CASE
S
Syst
emic
and l
oco-
greg
iona
l the
rapi
es in
a pt
with
adva
nced
HCC
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
PRO
FFER
ED P
APER
SPEC
IAL
SYM
POSI
UM
Geno
mic
inst
abili
ty fr
om
benc
h to b
edsi
de
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
PRO
FFER
ED P
APER
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
PRES
IDEN
TIAL
SY
MPO
SIU
M 2
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
PRO
FFER
ED P
APER
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
PRO
FFER
ED P
APER
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
POST
ER
DIS
CUSS
ION
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
POST
ER
DIS
CUSS
ION
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
POST
ER
DIS
CUSS
ION
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
POST
ER
DIS
CUSS
ION
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
POST
ER
DIS
CUSS
ION
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
POST
ER
DIS
CUSS
ION
ABST
RAC
T-R
ELAT
ED S
ESSI
ON
POST
ER
DIS
CUSS
ION
KEYN
OTE
LEC
TUR
E
Ratio
nal d
rug
com
bina
tions
IND
UST
RY
SATE
LLIT
E SY
MPO
SIU
MIN
DU
STR
Y SA
TELL
ITE
SYM
POSI
UM
IND
UST
RY
SATE
LLIT
E SY
MPO
SIU
MIN
DU
STR
Y SA
TELL
ITE
SYM
POSI
UM
IND
UST
RY
SATE
LLIT
E SY
MPO
SIU
MIN
DU
STR
Y SA
TELL
ITE
SYM
POSI
UM
IND
UST
RY
SATE
LLIT
E SY
MPO
SIU
M
Tues
day,
30 S
eptem
ber
Mad
ridBa
rcelo
naSe
villa
Gran
ada
Cord
oba
Pam
plon
aVa
lenc
iaAl
ican
teBi
lbao
Sala
man
caSa
n Seb
astia
nOv
iedo
08:0
0
08:3
0
09:0
0
09:3
0
10:0
0
10:3
0
11.0
0
11:3
0
12:0
0
12:3
0
13:0
0
CON
GR
ESS
HIG
HLI
GH
TS 1
CYE
Adju
vant
trea
tmen
t of
brea
st ca
ncer
CYE
SCLC
: Cur
rent
ap
proa
ches
and R
T in
exte
nsiv
e dis
ease
CYE
Thro
mbo
embo
lic
diso
rder
s in o
ncol
ogy
CYE
Curr
ent d
iagn
osis
and
treat
men
t of C
UP
CON
GR
ESS
HIG
HLI
GH
TS 2
Abst
ract
-rel
ated
sess
ions
Basi
c sci
ence
and t
rans
latio
nal r
esea
rch
Brea
st ca
ncer
CNS
tum
ours
Deve
lopm
enta
l the
rape
utic
s
Fam
ilial
canc
ers a
nd g
enet
ic sy
ndro
mes
Gast
roin
test
inal
tum
ours
Geni
tour
inar
y tum
ours
Gyna
ecol
ogic
al ca
ncer
s
Haem
atol
ogic
al m
align
anci
es
Head
and n
eck c
ance
r
Imm
unot
hera
py o
f can
cer
Indu
stry
Sat
ellite
Sym
posiu
m
Lung
canc
er an
d oth
er th
orac
ic m
align
anci
es
Mel
anom
a and
oth
er sk
in tu
mou
rs
NETs
and e
ndoc
rine t
umou
rs
Patie
nt A
dvoc
acy T
rack
Publ
ic he
alth
and h
ealth
econ
omic
s
Key
Sarc
oma
Supp
ortiv
e and
pall
iativ
e car
e
Gene
ral in
tere
st
Youn
g onc
olog
ists
(YO)
Disc
laim
er: s
essi
on ti
min
gs m
ay b
e sub
ject
to ch
ange
with
in th
e sam
e day
.
ESM_Madrid2014_AdvPreProgr_Leaflet-6pages.indd 1-3 07/03/14 15:41
Friday, 26 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo Zaragoza
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
OPENING SESSION
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
YOMASTERCLASS
ESMO YOs meet the EACR:
Integrating basic science into clinical
research
YO VESALIUS TALK
Paving your own path to success
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
ESMO GENERAL ASSEMBLY
(open to ESMO Members only)
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUMINDUSTRY SATELLITE
SYMPOSIUMINDUSTRY SATELLITE
SYMPOSIUM
Abstract-related sessions
Basic science and translational research
Breast cancer
CNS tumours
Developmental therapeutics
Familial cancers and genetic syndromes
Gastrointestinal tumours
Genitourinary tumours
Gynaecological cancers
Haematological malignancies
Head and neck cancer
Immunotherapy of cancer
Industry Satellite Symposium
Lung cancer and other thoracic malignancies
Melanoma and other skin tumours
NETs and endocrine tumours
Patient Advocacy Track
Public health and health economics
Key
Sarcoma
Supportive and palliative care
General interest
Young oncologists (YO)
Disclaimer: session timings may be subject to change within the same day.
Saturday, 27 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo Zaragoza
08:00
08:30
09:00
09:30
10:00
10:30
11.00
11:30
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
EDUCATIONAL SESSION
Systemic treatment of metastatic NSCLC
EDUCATIONAL SESSION
Clinical issues in metastatic NSCLC
EDUCATIONAL SESSION
Optimising the treatment of colorectal
cancer
PATIENT CASES
Therapeutic challenges in oncogene addicted
lung cancer
PATIENT CASES
Multimodal treatment approaches in bladder
cancer
CYE
Medical treatment for advanced endometrial
cancer
CYE
Is hormone therapy really harmless in elderly people?
CYE
Management of relapsed germ cell
tumours
CYE
Larynx preservation: How should we decide
the best treatment?
YO BREAKFAST
How to address the media
EDUCATIONAL SESSION
Management of breast cancer in specifi c
populations
EDUCATIONAL SESSION
Update in the management of
metastatic breast cancers
EDUCATIONAL SESSION
Biology must guide the treatment in sarcoma
JOINT SYMPOSIUM ESMO - ESP
Tissue markers for immuno-oncology
EDUCATIONAL SESSION
Ovarian cancer
EDUCATIONAL SESSION
Update in genitourinary
oncology
EDUCATIONAL SESSION
A multidisciplinary approach to
locoregionally advanced rectal cancer
EDUCATIONAL SESSION
Management of breast cancer in specifi c
populations
EDUCATIONAL SESSION
Clinical impact of tumour biology in
the management of oesophago-gastric
cancer
SPECIAL SYMPOSIUM
Personalised medicine in head and
neck cancer
SPECIAL SYMPOSIUM
Precision medicine in prostate cancer
SPECIAL SYMPOSIUM
The science behind combinations with immunotherapy in
melanoma
SPECIAL SYMPOSIUM
Targeting precision medicine toxicity
SPECIAL SYMPOSIUM
Signalling pathways in haemat. End
histopathological classifi cation / chemo
era?
JOINT SYMPOSIUMESMO-AORTIC-
SLACOM-UICC-WHO
Personalised cancer care/limited resources
SPECIAL SESSION
Optimal use of systemic therapy in the palliative setting
SOCIETY SESSION 1
SOCIETY SESSION 2
SOCIETY SESSION 3SPECIAL SESSION
Liquid biopsy: Monitoring tumour-
derived cell-free DNA, CTCs and exosomes in pts with solid tumours
EDUCATIONAL SESSION
Skin tumours update
PATIENT ADVOCACY TRACK
PATIENT ADVOCACY TRACK
EDUCATIONAL SESSION
Symptoms in oncology
SPECIAL SYMPOSIUM
Germline genetics: Important issues for
oncologists
PATIENT CASES
Immuno or targeted therapy oncogene
addicted melanoma
KEYNOTE LECTURE
Delivering precision immunotherapy
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
PATIENT CASES
Cancer evolution: What can we learn from N=1
molecular studies?
PATIENT CASES
Pregnancy and fertility preservation
PATIENT CASES
Challenging cases of oligometastatic
NSCLC
PATIENT CASES
Avoiding overdiagnosis and overtreatment: Cancer screening
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
ESMO EXAMINATION
(open to registered entrants only)
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
JOINT SYMPOSIUM ESMO-CSCO
Global collaboration in phase I cancer drug
development
Sunday, 28 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo Zaragoza
08:00
08:30
09:00
09:30
10:00
10:30
11.00
11:30
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
SPECIAL SYMPOSIUM
Molecular profi ling: Challenges and
perspectives
EDUCATIONAL SESSION
Systemic treatment of metastatic NSCLC
EDUCATIONAL SESSION
A multidisciplinary approach to
locoregionally advanced rectal cancer
EDUCATIONAL SESSION
Update in genitourinary
oncology
EDUCATIONAL SESSION
Ovarian cancer
EDUCATIONAL SESSION
Fundamental principles of cancer
immunotherapy: What the clinician needs
to know
EDUCATIONAL SESSION
Update in the management of
metastatic breast cancers
SPECIAL SESSION
Evasion, activation and manipulation of the cancer immuno
response
EDUCATIONAL SESSION
Clinical issues in metastatic NSCLC
CONTROVERSY SESSION 1
CONTROVERSY SESSION 2
ESMO CLINICAL PRACTICE
GUIDELINES 1
ESMO CLINICAL PRACTICE
GUIDELINES 2
ABSTRACT-RELATED SESSION
PRESIDENTIAL SYMPOSIUM 1
PATIENT CASES
Targeting intrinsic subtypes of metastatic bca/endocrine therapy
PATIENT CASES
Clinical and ethical issues in cancer
genetics
SPECIAL SYMPOSIUM
Residual disease after neoadjuvant therapies
SPECIAL SYMPOSIUM
Targeted therapy in gynaecological
cancer
SPECIAL SYMPOSIUM
Current concepts and future avenues in
meningioma
SPECIAL SYMPOSIUM
Neuroendocrine tumours: The cutting edge and a glimpse
into the future
SPECIAL SESSION
Availability of anti-neoplastic medicines
in Europe
SPECIAL SYMPOSIUM
Advances in precision medicine of metastatic
colorectal cancer
PATIENT CASES
Challenges in oligo-metastatic disease/
metastatic CRC
CYE
Medical treatment for advanced endometrial
cancer
CYE
Is hormone therapy really harmless in elderly people?
MIS
Locally advanced nasopharyngeal
carcinoma
MIS
Mgmt of brain mets: Surgery vs radiation vs late intervention
PATIENT CASES
How does one manage rare neuroendocrine
malignancies?
PATIENT CASES
Objectives in the management of pts
with brain mets
PATIENT CASES
Treatment of medullary thyroid
cancer (MTC)
PATIENT CASES
The management of isolated lung
metastases from STS
CYE
Management of relapsed germ cell
tumours
CYE
Larynx preservation: How should we decide
the best treatment?
YO BREAKFAST
Work-life balance
JOINT SYMPOSIUM ESMO-JSMO
How to integrate genome sequencing
data in oncology
JOINT SYMPOSIUM ESMO-EONS
Oral tumour therapy/enhanced patient
adherence
MIS
Management of localised endometrial
cancer
KEYNOTE LECTURE
Reclassifying cancer through genomics
EDUCATIONAL SESSION
Actual issues in neurooncology PATIENT ADVOCACY
TRACK
PATIENT ADVOCACY TRACK
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
SOCIETY SESSION 4
SOCIETY SESSION 5
ESM_M
adrid2014_AdvPreProgr_Leaflet-6pages.indd 4-607/03/14 15:41
Friday, 26 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo Zaragoza
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
OPENING SESSION
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
YOMASTERCLASS
ESMO YOs meet the EACR:
Integrating basic science into clinical
research
YO VESALIUS TALK
Paving your own path to success
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
ESMO GENERAL ASSEMBLY
(open to ESMO Members only)
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUMINDUSTRY SATELLITE
SYMPOSIUMINDUSTRY SATELLITE
SYMPOSIUM
Abstract-related sessions
Basic science and translational research
Breast cancer
CNS tumours
Developmental therapeutics
Familial cancers and genetic syndromes
Gastrointestinal tumours
Genitourinary tumours
Gynaecological cancers
Haematological malignancies
Head and neck cancer
Immunotherapy of cancer
Industry Satellite Symposium
Lung cancer and other thoracic malignancies
Melanoma and other skin tumours
NETs and endocrine tumours
Patient Advocacy Track
Public health and health economics
Key
Sarcoma
Supportive and palliative care
General interest
Young oncologists (YO)
Disclaimer: session timings may be subject to change within the same day.
Saturday, 27 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo Zaragoza
08:00
08:30
09:00
09:30
10:00
10:30
11.00
11:30
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
EDUCATIONAL SESSION
Systemic treatment of metastatic NSCLC
EDUCATIONAL SESSION
Clinical issues in metastatic NSCLC
EDUCATIONAL SESSION
Optimising the treatment of colorectal
cancer
PATIENT CASES
Therapeutic challenges in oncogene addicted
lung cancer
PATIENT CASES
Multimodal treatment approaches in bladder
cancer
CYE
Medical treatment for advanced endometrial
cancer
CYE
Is hormone therapy really harmless in elderly people?
CYE
Management of relapsed germ cell
tumours
CYE
Larynx preservation: How should we decide
the best treatment?
YO BREAKFAST
How to address the media
EDUCATIONAL SESSION
Management of breast cancer in specifi c
populations
EDUCATIONAL SESSION
Update in the management of
metastatic breast cancers
EDUCATIONAL SESSION
Biology must guide the treatment in sarcoma
JOINT SYMPOSIUM ESMO - ESP
Tissue markers for immuno-oncology
EDUCATIONAL SESSION
Ovarian cancer
EDUCATIONAL SESSION
Update in genitourinary
oncology
EDUCATIONAL SESSION
A multidisciplinary approach to
locoregionally advanced rectal cancer
EDUCATIONAL SESSION
Management of breast cancer in specifi c
populations
EDUCATIONAL SESSION
Clinical impact of tumour biology in
the management of oesophago-gastric
cancer
SPECIAL SYMPOSIUM
Personalised medicine in head and
neck cancer
SPECIAL SYMPOSIUM
Precision medicine in prostate cancer
SPECIAL SYMPOSIUM
The science behind combinations with immunotherapy in
melanoma
SPECIAL SYMPOSIUM
Targeting precision medicine toxicity
SPECIAL SYMPOSIUM
Signalling pathways in haemat. End
histopathological classifi cation / chemo
era?
JOINT SYMPOSIUMESMO-AORTIC-
SLACOM-UICC-WHO
Personalised cancer care/limited resources
SPECIAL SESSION
Optimal use of systemic therapy in the palliative setting
SOCIETY SESSION 1
SOCIETY SESSION 2
SOCIETY SESSION 3SPECIAL SESSION
Liquid biopsy: Monitoring tumour-
derived cell-free DNA, CTCs and exosomes in pts with solid tumours
EDUCATIONAL SESSION
Skin tumours update
PATIENT ADVOCACY TRACK
PATIENT ADVOCACY TRACK
EDUCATIONAL SESSION
Symptoms in oncology
SPECIAL SYMPOSIUM
Germline genetics: Important issues for
oncologists
PATIENT CASES
Immuno or targeted therapy oncogene
addicted melanoma
KEYNOTE LECTURE
Delivering precision immunotherapy
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
PATIENT CASES
Cancer evolution: What can we learn from N=1
molecular studies?
PATIENT CASES
Pregnancy and fertility preservation
PATIENT CASES
Challenging cases of oligometastatic
NSCLC
PATIENT CASES
Avoiding overdiagnosis and overtreatment: Cancer screening
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
ESMO EXAMINATION
(open to registered entrants only)
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
JOINT SYMPOSIUM ESMO-CSCO
Global collaboration in phase I cancer drug
development
Sunday, 28 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo Zaragoza
08:00
08:30
09:00
09:30
10:00
10:30
11.00
11:30
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
SPECIAL SYMPOSIUM
Molecular profi ling: Challenges and
perspectives
EDUCATIONAL SESSION
Systemic treatment of metastatic NSCLC
EDUCATIONAL SESSION
A multidisciplinary approach to
locoregionally advanced rectal cancer
EDUCATIONAL SESSION
Update in genitourinary
oncology
EDUCATIONAL SESSION
Ovarian cancer
EDUCATIONAL SESSION
Fundamental principles of cancer
immunotherapy: What the clinician needs
to know
EDUCATIONAL SESSION
Update in the management of
metastatic breast cancers
SPECIAL SESSION
Evasion, activation and manipulation of the cancer immuno
response
EDUCATIONAL SESSION
Clinical issues in metastatic NSCLC
CONTROVERSY SESSION 1
CONTROVERSY SESSION 2
ESMO CLINICAL PRACTICE
GUIDELINES 1
ESMO CLINICAL PRACTICE
GUIDELINES 2
ABSTRACT-RELATED SESSION
PRESIDENTIAL SYMPOSIUM 1
PATIENT CASES
Targeting intrinsic subtypes of metastatic bca/endocrine therapy
PATIENT CASES
Clinical and ethical issues in cancer
genetics
SPECIAL SYMPOSIUM
Residual disease after neoadjuvant therapies
SPECIAL SYMPOSIUM
Targeted therapy in gynaecological
cancer
SPECIAL SYMPOSIUM
Current concepts and future avenues in
meningioma
SPECIAL SYMPOSIUM
Neuroendocrine tumours: The cutting edge and a glimpse
into the future
SPECIAL SESSION
Availability of anti-neoplastic medicines
in Europe
SPECIAL SYMPOSIUM
Advances in precision medicine of metastatic
colorectal cancer
PATIENT CASES
Challenges in oligo-metastatic disease/
metastatic CRC
CYE
Medical treatment for advanced endometrial
cancer
CYE
Is hormone therapy really harmless in elderly people?
MIS
Locally advanced nasopharyngeal
carcinoma
MIS
Mgmt of brain mets: Surgery vs radiation vs late intervention
PATIENT CASES
How does one manage rare neuroendocrine
malignancies?
PATIENT CASES
Objectives in the management of pts
with brain mets
PATIENT CASES
Treatment of medullary thyroid
cancer (MTC)
PATIENT CASES
The management of isolated lung
metastases from STS
CYE
Management of relapsed germ cell
tumours
CYE
Larynx preservation: How should we decide
the best treatment?
YO BREAKFAST
Work-life balance
JOINT SYMPOSIUM ESMO-JSMO
How to integrate genome sequencing
data in oncology
JOINT SYMPOSIUM ESMO-EONS
Oral tumour therapy/enhanced patient
adherence
MIS
Management of localised endometrial
cancer
KEYNOTE LECTURE
Reclassifying cancer through genomics
EDUCATIONAL SESSION
Actual issues in neurooncology PATIENT ADVOCACY
TRACK
PATIENT ADVOCACY TRACK
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
SOCIETY SESSION 4
SOCIETY SESSION 5
ESM_M
adrid2014_AdvPreProgr_Leaflet-6pages.indd 4-607/03/14 15:41
Friday, 26 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo Zaragoza
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
OPENING SESSION
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
YOMASTERCLASS
ESMO YOs meet the EACR:
Integrating basic science into clinical
research
YO VESALIUS TALK
Paving your own path to success
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
ESMO GENERAL ASSEMBLY
(open to ESMO Members only)
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUM
INDUSTRY SATELLITE
SYMPOSIUMINDUSTRY SATELLITE
SYMPOSIUMINDUSTRY SATELLITE
SYMPOSIUM
Abstract-related sessions
Basic science and translational research
Breast cancer
CNS tumours
Developmental therapeutics
Familial cancers and genetic syndromes
Gastrointestinal tumours
Genitourinary tumours
Gynaecological cancers
Haematological malignancies
Head and neck cancer
Immunotherapy of cancer
Industry Satellite Symposium
Lung cancer and other thoracic malignancies
Melanoma and other skin tumours
NETs and endocrine tumours
Patient Advocacy Track
Public health and health economics
Key
Sarcoma
Supportive and palliative care
General interest
Young oncologists (YO)
Disclaimer: session timings may be subject to change within the same day.
Saturday, 27 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo Zaragoza
08:00
08:30
09:00
09:30
10:00
10:30
11.00
11:30
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
EDUCATIONAL SESSION
Systemic treatment of metastatic NSCLC
EDUCATIONAL SESSION
Clinical issues in metastatic NSCLC
EDUCATIONAL SESSION
Optimising the treatment of colorectal
cancer
PATIENT CASES
Therapeutic challenges in oncogene addicted
lung cancer
PATIENT CASES
Multimodal treatment approaches in bladder
cancer
CYE
Medical treatment for advanced endometrial
cancer
CYE
Is hormone therapy really harmless in elderly people?
CYE
Management of relapsed germ cell
tumours
CYE
Larynx preservation: How should we decide
the best treatment?
YO BREAKFAST
How to address the media
EDUCATIONAL SESSION
Management of breast cancer in specifi c
populations
EDUCATIONAL SESSION
Update in the management of
metastatic breast cancers
EDUCATIONAL SESSION
Biology must guide the treatment in sarcoma
JOINT SYMPOSIUM ESMO - ESP
Tissue markers for immuno-oncology
EDUCATIONAL SESSION
Ovarian cancer
EDUCATIONAL SESSION
Update in genitourinary
oncology
EDUCATIONAL SESSION
A multidisciplinary approach to
locoregionally advanced rectal cancer
EDUCATIONAL SESSION
Management of breast cancer in specifi c
populations
EDUCATIONAL SESSION
Clinical impact of tumour biology in
the management of oesophago-gastric
cancer
SPECIAL SYMPOSIUM
Personalised medicine in head and
neck cancer
SPECIAL SYMPOSIUM
Precision medicine in prostate cancer
SPECIAL SYMPOSIUM
The science behind combinations with immunotherapy in
melanoma
SPECIAL SYMPOSIUM
Targeting precision medicine toxicity
SPECIAL SYMPOSIUM
Signalling pathways in haemat. End
histopathological classifi cation / chemo
era?
JOINT SYMPOSIUMESMO-AORTIC-
SLACOM-UICC-WHO
Personalised cancer care/limited resources
SPECIAL SESSION
Optimal use of systemic therapy in the palliative setting
SOCIETY SESSION 1
SOCIETY SESSION 2
SOCIETY SESSION 3SPECIAL SESSION
Liquid biopsy: Monitoring tumour-
derived cell-free DNA, CTCs and exosomes in pts with solid tumours
EDUCATIONAL SESSION
Skin tumours update
PATIENT ADVOCACY TRACK
PATIENT ADVOCACY TRACK
EDUCATIONAL SESSION
Symptoms in oncology
SPECIAL SYMPOSIUM
Germline genetics: Important issues for
oncologists
PATIENT CASES
Immuno or targeted therapy oncogene
addicted melanoma
KEYNOTE LECTURE
Delivering precision immunotherapy
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
PATIENT CASES
Cancer evolution: What can we learn from N=1
molecular studies?
PATIENT CASES
Pregnancy and fertility preservation
PATIENT CASES
Challenging cases of oligometastatic
NSCLC
PATIENT CASES
Avoiding overdiagnosis and overtreatment: Cancer screening
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
ESMO EXAMINATION
(open to registered entrants only)
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
JOINT SYMPOSIUM ESMO-CSCO
Global collaboration in phase I cancer drug
development
Sunday, 28 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo Zaragoza
08:00
08:30
09:00
09:30
10:00
10:30
11.00
11:30
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
SPECIAL SYMPOSIUM
Molecular profi ling: Challenges and
perspectives
EDUCATIONAL SESSION
Systemic treatment of metastatic NSCLC
EDUCATIONAL SESSION
A multidisciplinary approach to
locoregionally advanced rectal cancer
EDUCATIONAL SESSION
Update in genitourinary
oncology
EDUCATIONAL SESSION
Ovarian cancer
EDUCATIONAL SESSION
Fundamental principles of cancer
immunotherapy: What the clinician needs
to know
EDUCATIONAL SESSION
Update in the management of
metastatic breast cancers
SPECIAL SESSION
Evasion, activation and manipulation of the cancer immuno
response
EDUCATIONAL SESSION
Clinical issues in metastatic NSCLC
CONTROVERSY SESSION 1
CONTROVERSY SESSION 2
ESMO CLINICAL PRACTICE
GUIDELINES 1
ESMO CLINICAL PRACTICE
GUIDELINES 2
ABSTRACT-RELATED SESSION
PRESIDENTIAL SYMPOSIUM 1
PATIENT CASES
Targeting intrinsic subtypes of metastatic bca/endocrine therapy
PATIENT CASES
Clinical and ethical issues in cancer
genetics
SPECIAL SYMPOSIUM
Residual disease after neoadjuvant therapies
SPECIAL SYMPOSIUM
Targeted therapy in gynaecological
cancer
SPECIAL SYMPOSIUM
Current concepts and future avenues in
meningioma
SPECIAL SYMPOSIUM
Neuroendocrine tumours: The cutting edge and a glimpse
into the future
SPECIAL SESSION
Availability of anti-neoplastic medicines
in Europe
SPECIAL SYMPOSIUM
Advances in precision medicine of metastatic
colorectal cancer
PATIENT CASES
Challenges in oligo-metastatic disease/
metastatic CRC
CYE
Medical treatment for advanced endometrial
cancer
CYE
Is hormone therapy really harmless in elderly people?
MIS
Locally advanced nasopharyngeal
carcinoma
MIS
Mgmt of brain mets: Surgery vs radiation vs late intervention
PATIENT CASES
How does one manage rare neuroendocrine
malignancies?
PATIENT CASES
Objectives in the management of pts
with brain mets
PATIENT CASES
Treatment of medullary thyroid
cancer (MTC)
PATIENT CASES
The management of isolated lung
metastases from STS
CYE
Management of relapsed germ cell
tumours
CYE
Larynx preservation: How should we decide
the best treatment?
YO BREAKFAST
Work-life balance
JOINT SYMPOSIUM ESMO-JSMO
How to integrate genome sequencing
data in oncology
JOINT SYMPOSIUM ESMO-EONS
Oral tumour therapy/enhanced patient
adherence
MIS
Management of localised endometrial
cancer
KEYNOTE LECTURE
Reclassifying cancer through genomics
EDUCATIONAL SESSION
Actual issues in neurooncology PATIENT ADVOCACY
TRACK
PATIENT ADVOCACY TRACK
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
SOCIETY SESSION 4
SOCIETY SESSION 5
ESM_M
adrid2014_AdvPreProgr_Leaflet-6pages.indd 4-607/03/14 15:41
esmocongress.org
Organiser
PROGRAMM
EOVERVIEW
ESMO 2014
26-30 SEPTEMBER 2014
Madrid
Spain
Monday, 29 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Zaragoza
08:00
08:30
09:00
09:30
10:00
10:30
11.00
11:30
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
CONTROVERSY SESSION 3
CONTROVERSY SESSION 4
CONTROVERSY SESSION 5
CONTROVERSY SESSION 6
CONTROVERSY SESSION 7
PATIENT CASES
Treatment of CRPC in special situations
PATIENT CASES
Challenges in managing breast cancer in young
patients
PATIENT CASES
Demonstrating the emergence of resistance
PATIENT CASES
Primary surgery or neoadj. chemo ovarian/
pt selection
CYE
Adjuvant treatment of breast cancer
CYE
SCLC: Current approaches and RT in
extensive disease
CYE
Thromboembolic disorders in oncology
CYE
Current diagnosis and treatment of CUP
YO BREAKFAST
Doctor/pt relationship
YO FORUM
Tips and tricks for cancer researchers in
training
YO SPECIAL SESSION
Fellowships in Europe: Educational
opportunities for young oncologists
SPECIAL SESSION
How clinical trials could have been done, and
were not, in rare cancers
SPECIAL SYMPOSIUM
Activating immune response to cancer
ABSTRACT-RELATED SESSION PROFFERED PAPER
JOINT SYMPOSIUM ESMO-ESTRO-ESSO
Integration of local therapy with systemic treatment in oligometastatic breast
cancer
JOINT SYMPOSIUM ESMO-SEOM
Investigation driven precision oncology
JOINT SYMPOSIUM ESMO-EANM
Impact of molecular imaging on management
of lymphoma
SPECIAL SYMPOSIUM
The evolving role of systemic treatment in
advanced NSCLC
SPECIAL SYMPOSIUM
Beyond tumour heterogeneity: New pathways in kidney
cancer
SPECIAL SYMPOSIUM
Cancer immunotherapy in breast cancer: Dream
or reality?
JOINT SYMPOSIUMESMO-ASCO
The evolution of the clinical trials landscape
SPECIAL SYMPOSIUM
The impact on health services from
personalised targeted therapies
SPECIAL SYMPOSIUM
Diagnostic and therapeutic challenges
in thoracic malignancies
SPECIAL SYMPOSIUM
Towards personalised medicine in gastric, pancreatic and liver
cancer: From “omics” research to treatment
SPECIAL SYMPOSIUM
Controversies in the neo-adjuvant treatment of localised soft tissue
sarcomas (STS)
SPECIAL SESSION
Precision medicine : Panacea or false dawn?
EDUCATIONAL SESSION
Update on all neuroendocrine tumours
EDUCATIONAL SESSION
Optimising the treatment of colorectal cancer
EDUCATIONAL SESSION
Major lymphoma subtypes in the elderly
EDUCATIONAL SESSION
Cancer in young adults (18-35)
MIS
Locally advanced pancreatic cancer
PATIENT CASES
Imaging decisions in haematological
malignancies
PATIENT CASES
Immunotherapy in clinical practice
MIS
Sequence of treatment in crc with synchronous
metastases
MIS
Multidisciplinary mgmt of peritoneal
carcinomatosis
PATIENT CASES
Systemic and loco-gregional therapies in a pt with advanced HCC
ABSTRACT-RELATED SESSION PROFFERED PAPER
SPECIAL SYMPOSIUM
Genomic instability from bench to bedside
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION
PRESIDENTIAL SYMPOSIUM 2
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
KEYNOTE LECTURE
Rational drug combinations
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
Tuesday, 30 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo
08:00
08:30
09:00
09:30
10:00
10:30
11.00
11:30
12:00
12:30
13:00
CONGRESS HIGHLIGHTS 1
CYE
Adjuvant treatment of breast cancer
CYE
SCLC: Current approaches and RT in
extensive disease
CYE
Thromboembolic disorders in oncology
CYE
Current diagnosis and treatment of CUP
CONGRESS HIGHLIGHTS 2
Abstract-related sessions
Basic science and translational research
Breast cancer
CNS tumours
Developmental therapeutics
Familial cancers and genetic syndromes
Gastrointestinal tumours
Genitourinary tumours
Gynaecological cancers
Haematological malignancies
Head and neck cancer
Immunotherapy of cancer
Industry Satellite Symposium
Lung cancer and other thoracic malignancies
Melanoma and other skin tumours
NETs and endocrine tumours
Patient Advocacy Track
Public health and health economics
Key
Sarcoma
Supportive and palliative care
General interest
Young oncologists (YO)
Disclaimer: session timings may be subject to change within the same day.
ESM_M
adrid2014_AdvPreProgr_Leaflet-6pages.indd 1-307/03/14 15:41
Disclaimer: session timings may be subject to change within the same day.
esmocongress.org
Organiser
PROGRAMM
EOVERVIEW
ESMO 2014
26-30 SEPTEMBER 2014
Madrid
Spain
Monday, 29 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Zaragoza
08:00
08:30
09:00
09:30
10:00
10:30
11.00
11:30
12:00
12:30
13:00
13:30
14:00
14:30
15:00
15:30
16:00
16:30
17:00
17:30
18:00
18:30
19:00
19:30
20:00
CONTROVERSY SESSION 3
CONTROVERSY SESSION 4
CONTROVERSY SESSION 5
CONTROVERSY SESSION 6
CONTROVERSY SESSION 7
PATIENT CASES
Treatment of CRPC in special situations
PATIENT CASES
Challenges in managing breast cancer in young
patients
PATIENT CASES
Demonstrating the emergence of resistance
PATIENT CASES
Primary surgery or neoadj. chemo ovarian/
pt selection
CYE
Adjuvant treatment of breast cancer
CYE
SCLC: Current approaches and RT in
extensive disease
CYE
Thromboembolic disorders in oncology
CYE
Current diagnosis and treatment of CUP
YO BREAKFAST
Doctor/pt relationship
YO FORUM
Tips and tricks for cancer researchers in
training
YO SPECIAL SESSION
Fellowships in Europe: Educational
opportunities for young oncologists
SPECIAL SESSION
How clinical trials could have been done, and
were not, in rare cancers
SPECIAL SYMPOSIUM
Activating immune response to cancer
ABSTRACT-RELATED SESSION PROFFERED PAPER
JOINT SYMPOSIUM ESMO-ESTRO-ESSO
Integration of local therapy with systemic treatment in oligometastatic breast
cancer
JOINT SYMPOSIUM ESMO-SEOM
Investigation driven precision oncology
JOINT SYMPOSIUM ESMO-EANM
Impact of molecular imaging on management
of lymphoma
SPECIAL SYMPOSIUM
The evolving role of systemic treatment in
advanced NSCLC
SPECIAL SYMPOSIUM
Beyond tumour heterogeneity: New pathways in kidney
cancer
SPECIAL SYMPOSIUM
Cancer immunotherapy in breast cancer: Dream
or reality?
JOINT SYMPOSIUMESMO-ASCO
The evolution of the clinical trials landscape
SPECIAL SYMPOSIUM
The impact on health services from
personalised targeted therapies
SPECIAL SYMPOSIUM
Diagnostic and therapeutic challenges
in thoracic malignancies
SPECIAL SYMPOSIUM
Towards personalised medicine in gastric, pancreatic and liver
cancer: From “omics” research to treatment
SPECIAL SYMPOSIUM
Controversies in the neo-adjuvant treatment of localised soft tissue
sarcomas (STS)
SPECIAL SESSION
Precision medicine : Panacea or false dawn?
EDUCATIONAL SESSION
Update on all neuroendocrine tumours
EDUCATIONAL SESSION
Optimising the treatment of colorectal cancer
EDUCATIONAL SESSION
Major lymphoma subtypes in the elderly
EDUCATIONAL SESSION
Cancer in young adults (18-35)
MIS
Locally advanced pancreatic cancer
PATIENT CASES
Imaging decisions in haematological
malignancies
PATIENT CASES
Immunotherapy in clinical practice
MIS
Sequence of treatment in crc with synchronous
metastases
MIS
Multidisciplinary mgmt of peritoneal
carcinomatosis
PATIENT CASES
Systemic and loco-gregional therapies in a pt with advanced HCC
ABSTRACT-RELATED SESSION PROFFERED PAPER
SPECIAL SYMPOSIUM
Genomic instability from bench to bedside
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION
PRESIDENTIAL SYMPOSIUM 2
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION PROFFERED PAPER
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
ABSTRACT-RELATED SESSION
POSTER DISCUSSION
KEYNOTE LECTURE
Rational drug combinations
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
INDUSTRY SATELLITE SYMPOSIUM
Tuesday, 30 September
Madrid Barcelona Sevilla Granada Cordoba Pamplona Valencia Alicante Bilbao Salamanca San Sebastian Oviedo
08:00
08:30
09:00
09:30
10:00
10:30
11.00
11:30
12:00
12:30
13:00
CONGRESS HIGHLIGHTS 1
CYE
Adjuvant treatment of breast cancer
CYE
SCLC: Current approaches and RT in
extensive disease
CYE
Thromboembolic disorders in oncology
CYE
Current diagnosis and treatment of CUP
CONGRESS HIGHLIGHTS 2
Abstract-related sessions
Basic science and translational research
Breast cancer
CNS tumours
Developmental therapeutics
Familial cancers and genetic syndromes
Gastrointestinal tumours
Genitourinary tumours
Gynaecological cancers
Haematological malignancies
Head and neck cancer
Immunotherapy of cancer
Industry Satellite Symposium
Lung cancer and other thoracic malignancies
Melanoma and other skin tumours
NETs and endocrine tumours
Patient Advocacy Track
Public health and health economics
Key
Sarcoma
Supportive and palliative care
General interest
Young oncologists (YO)
Disclaimer: session timings may be subject to change within the same day.
ESM_M
adrid2014_AdvPreProgr_Leaflet-6pages.indd 1-307/03/14 15:41